Edwards Lifesciences Net Cash Flow from Operations Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 111.2  1.88  1.66%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Net Cash Flow from Operations of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of Net Cash Flow or Change in Cash and Cash Equivalents representing the amount of cash inflow (outflow) from operating activities, from continuing and discontinued operations.
View

733 M

            10 Years Trend  
Increasing
Slightly volatile
 Net Cash Flow from Operations 
      Timeline 

Edwards Lifesciences Net Cash Flow from Operations Over Time

2015-12-31  549,700,000 
2016-12-31  704,400,000 
2017-12-31  733,000,000 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  419,716,667
Geometric Mean  336,416,989
Coefficient Of Variation  67.62
Mean Deviation  230,586,111
Median  362,100,000
Standard Deviation  283,803,558
Range  921,100,000
R Value  0.85
R Squared  0.72
Significance  0.00045286
Slope  66,957,343

Currently Trending

V   
 NYQ 
Purchased over 20 shares of
a day ago ago
Traded for 107.02
GOOG   
 NMS 
Purchased few shares of
a day ago ago
Traded for 984.45
VMW   
 NYQ 
Purchased over 20 shares of
a day ago ago
Traded for 117.4